Vanguard Group’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.49M | Buy |
|
|||||
|
2025
Q1 | $2.77M | Sell |
|
|||||
|
2024
Q4 | $3.17M | Buy |
|
|||||
|
2024
Q3 | $3.61M | Buy |
|
|||||
|
2024
Q2 | $3.76M | Buy |
|
|||||
|
2024
Q1 | $2.92M | Buy |
|
|||||
|
2023
Q4 | $2.56M | Buy |
|
|||||
|
2023
Q3 | $1.57M | Buy |
|
|||||
|
2023
Q2 | $1.03M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $927K | Sell |
|
|||||
|
2021
Q4 | $1.01M | Buy |
|
|||||
|
2021
Q3 | $1.74M | Buy |
|
|||||
|
2021
Q2 | $1.47M | Buy |
|
|||||
|
2021
Q1 | $1.81M | Buy |
|
|||||
|
2020
Q4 | $1.5M | Buy |
|
|||||
|
2020
Q3 | $1.45M | Sell |
|
|||||
|
2020
Q2 | $2.04M | Sell |
|
|||||
|
2020
Q1 | $1.45M | Buy |
|
|||||
|
2019
Q4 | $2.69M | Sell |
|
|||||
|
2019
Q3 | $1.95M | Buy |
|
|||||
|
2019
Q2 | $2.53M | Buy |
|
|||||
|
2019
Q1 | $278K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $208K | Buy |
|